nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—ADRA2A—epilepsy syndrome	0.103	0.308	CbGaD
Pseudoephedrine—TNF—epilepsy syndrome	0.0974	0.292	CbGaD
Pseudoephedrine—SLC6A4—epilepsy syndrome	0.0784	0.235	CbGaD
Pseudoephedrine—Bethanidine—Lacosamide—epilepsy syndrome	0.0674	0.2	CrCrCtD
Pseudoephedrine—Mephentermine—Lacosamide—epilepsy syndrome	0.0646	0.192	CrCrCtD
Pseudoephedrine—Phentermine—Lacosamide—epilepsy syndrome	0.0596	0.177	CrCrCtD
Pseudoephedrine—CYP2D6—epilepsy syndrome	0.0551	0.165	CbGaD
Pseudoephedrine—Dextroamphetamine—Lacosamide—epilepsy syndrome	0.0488	0.145	CrCrCtD
Pseudoephedrine—Amphetamine—Lacosamide—epilepsy syndrome	0.0488	0.145	CrCrCtD
Pseudoephedrine—Methamphetamine—Lacosamide—epilepsy syndrome	0.0474	0.141	CrCrCtD
Pseudoephedrine—MAOA—Zonisamide—epilepsy syndrome	0.0425	0.856	CbGbCtD
Pseudoephedrine—CYP2D6—Propofol—epilepsy syndrome	0.00714	0.144	CbGbCtD
Pseudoephedrine—SLC6A2—locus ceruleus—epilepsy syndrome	0.00303	0.0721	CbGeAlD
Pseudoephedrine—MAOA—locus ceruleus—epilepsy syndrome	0.00279	0.0665	CbGeAlD
Pseudoephedrine—SLC6A3—telencephalic ventricle—epilepsy syndrome	0.00178	0.0424	CbGeAlD
Pseudoephedrine—SLC6A2—autonomic nervous system—epilepsy syndrome	0.00161	0.0383	CbGeAlD
Pseudoephedrine—SLC6A3—ganglion—epilepsy syndrome	0.00111	0.0264	CbGeAlD
Pseudoephedrine—NFATC1—head—epilepsy syndrome	0.0011	0.0262	CbGeAlD
Pseudoephedrine—NFATC1—nervous system—epilepsy syndrome	0.00104	0.0249	CbGeAlD
Pseudoephedrine—SLC6A4—ganglion—epilepsy syndrome	0.00102	0.0242	CbGeAlD
Pseudoephedrine—IL2—head—epilepsy syndrome	0.00101	0.024	CbGeAlD
Pseudoephedrine—NFATC1—central nervous system—epilepsy syndrome	0.00101	0.0239	CbGeAlD
Pseudoephedrine—NFATC1—cerebellum—epilepsy syndrome	0.000983	0.0234	CbGeAlD
Pseudoephedrine—IL2—nervous system—epilepsy syndrome	0.000956	0.0227	CbGeAlD
Pseudoephedrine—IL2—central nervous system—epilepsy syndrome	0.00092	0.0219	CbGeAlD
Pseudoephedrine—Etomidate—SLC2A1—epilepsy syndrome	0.000908	0.306	CrCbGaD
Pseudoephedrine—SLC6A2—ganglion—epilepsy syndrome	0.000895	0.0213	CbGeAlD
Pseudoephedrine—SLC6A3—hindbrain—epilepsy syndrome	0.000841	0.02	CbGeAlD
Pseudoephedrine—MAOA—ganglion—epilepsy syndrome	0.000824	0.0196	CbGeAlD
Pseudoephedrine—NFATC1—brain—epilepsy syndrome	0.000799	0.019	CbGeAlD
Pseudoephedrine—SLC6A4—hindbrain—epilepsy syndrome	0.000771	0.0183	CbGeAlD
Pseudoephedrine—IL2—brain—epilepsy syndrome	0.00073	0.0174	CbGeAlD
Pseudoephedrine—ADRA1A—hindbrain—epilepsy syndrome	0.000631	0.015	CbGeAlD
Pseudoephedrine—MAOA—hindbrain—epilepsy syndrome	0.000625	0.0149	CbGeAlD
Pseudoephedrine—SLC6A3—brainstem—epilepsy syndrome	0.000482	0.0115	CbGeAlD
Pseudoephedrine—SLC6A3—forebrain—epilepsy syndrome	0.000465	0.0111	CbGeAlD
Pseudoephedrine—SLC6A4—brainstem—epilepsy syndrome	0.000442	0.0105	CbGeAlD
Pseudoephedrine—ADRB1—forebrain—epilepsy syndrome	0.000441	0.0105	CbGeAlD
Pseudoephedrine—SLC6A3—telencephalon—epilepsy syndrome	0.000428	0.0102	CbGeAlD
Pseudoephedrine—SLC6A4—forebrain—epilepsy syndrome	0.000426	0.0101	CbGeAlD
Pseudoephedrine—ADRB1—telencephalon—epilepsy syndrome	0.000406	0.00966	CbGeAlD
Pseudoephedrine—SLC6A4—telencephalon—epilepsy syndrome	0.000392	0.00933	CbGeAlD
Pseudoephedrine—Etomidate—GABRG2—epilepsy syndrome	0.000389	0.131	CrCbGaD
Pseudoephedrine—SLC6A2—brainstem—epilepsy syndrome	0.000389	0.00926	CbGeAlD
Pseudoephedrine—SLC6A2—forebrain—epilepsy syndrome	0.000375	0.00893	CbGeAlD
Pseudoephedrine—CYP2D6—hindbrain—epilepsy syndrome	0.000371	0.00884	CbGeAlD
Pseudoephedrine—ADRA1A—brainstem—epilepsy syndrome	0.000361	0.0086	CbGeAlD
Pseudoephedrine—MAOA—brainstem—epilepsy syndrome	0.000358	0.00853	CbGeAlD
Pseudoephedrine—ADRA1A—forebrain—epilepsy syndrome	0.000349	0.0083	CbGeAlD
Pseudoephedrine—MAOA—forebrain—epilepsy syndrome	0.000346	0.00823	CbGeAlD
Pseudoephedrine—SLC6A2—telencephalon—epilepsy syndrome	0.000345	0.00821	CbGeAlD
Pseudoephedrine—ADRA1A—telencephalon—epilepsy syndrome	0.000321	0.00764	CbGeAlD
Pseudoephedrine—MAOA—telencephalon—epilepsy syndrome	0.000318	0.00757	CbGeAlD
Pseudoephedrine—SLC6A3—midbrain—epilepsy syndrome	0.000307	0.00731	CbGeAlD
Pseudoephedrine—SLC6A3—spinal cord—epilepsy syndrome	0.0003	0.00713	CbGeAlD
Pseudoephedrine—SLC6A4—midbrain—epilepsy syndrome	0.000281	0.0067	CbGeAlD
Pseudoephedrine—SLC6A4—spinal cord—epilepsy syndrome	0.000275	0.00654	CbGeAlD
Pseudoephedrine—Etomidate—GABRB2—epilepsy syndrome	0.000274	0.0923	CrCbGaD
Pseudoephedrine—SLC6A2—medulla oblongata—epilepsy syndrome	0.000271	0.00645	CbGeAlD
Pseudoephedrine—Etomidate—GABRA1—epilepsy syndrome	0.000269	0.0905	CrCbGaD
Pseudoephedrine—SLC6A3—head—epilepsy syndrome	0.000266	0.00634	CbGeAlD
Pseudoephedrine—ADRA2A—forebrain—epilepsy syndrome	0.000265	0.00631	CbGeAlD
Pseudoephedrine—ADRB1—head—epilepsy syndrome	0.000253	0.00601	CbGeAlD
Pseudoephedrine—SLC6A3—nervous system—epilepsy syndrome	0.000253	0.00601	CbGeAlD
Pseudoephedrine—MAOA—medulla oblongata—epilepsy syndrome	0.00025	0.00595	CbGeAlD
Pseudoephedrine—SLC6A4—head—epilepsy syndrome	0.000244	0.00581	CbGeAlD
Pseudoephedrine—ADRA2A—telencephalon—epilepsy syndrome	0.000244	0.00581	CbGeAlD
Pseudoephedrine—SLC6A3—central nervous system—epilepsy syndrome	0.000243	0.00579	CbGeAlD
Pseudoephedrine—ADRB1—nervous system—epilepsy syndrome	0.00024	0.0057	CbGeAlD
Pseudoephedrine—SLC6A3—cerebellum—epilepsy syndrome	0.000238	0.00566	CbGeAlD
Pseudoephedrine—SLC6A4—nervous system—epilepsy syndrome	0.000231	0.00551	CbGeAlD
Pseudoephedrine—ADRB1—central nervous system—epilepsy syndrome	0.000231	0.00549	CbGeAlD
Pseudoephedrine—MAOA—midbrain—epilepsy syndrome	0.000228	0.00543	CbGeAlD
Pseudoephedrine—SLC6A4—central nervous system—epilepsy syndrome	0.000223	0.0053	CbGeAlD
Pseudoephedrine—MAOA—spinal cord—epilepsy syndrome	0.000223	0.0053	CbGeAlD
Pseudoephedrine—SLC6A2—head—epilepsy syndrome	0.000215	0.00511	CbGeAlD
Pseudoephedrine—CYP2D6—brainstem—epilepsy syndrome	0.000213	0.00507	CbGeAlD
Pseudoephedrine—CYP2D6—forebrain—epilepsy syndrome	0.000205	0.00489	CbGeAlD
Pseudoephedrine—SLC6A2—nervous system—epilepsy syndrome	0.000204	0.00485	CbGeAlD
Pseudoephedrine—ADRA1A—head—epilepsy syndrome	0.0002	0.00476	CbGeAlD
Pseudoephedrine—MAOA—head—epilepsy syndrome	0.000198	0.00471	CbGeAlD
Pseudoephedrine—SLC6A2—central nervous system—epilepsy syndrome	0.000196	0.00467	CbGeAlD
Pseudoephedrine—SLC6A3—brain—epilepsy syndrome	0.000193	0.00459	CbGeAlD
Pseudoephedrine—ADRA2A—medulla oblongata—epilepsy syndrome	0.000192	0.00456	CbGeAlD
Pseudoephedrine—ADRA1A—nervous system—epilepsy syndrome	0.000189	0.00451	CbGeAlD
Pseudoephedrine—CYP2D6—telencephalon—epilepsy syndrome	0.000189	0.0045	CbGeAlD
Pseudoephedrine—MAOA—nervous system—epilepsy syndrome	0.000188	0.00447	CbGeAlD
Pseudoephedrine—ADRB1—brain—epilepsy syndrome	0.000183	0.00436	CbGeAlD
Pseudoephedrine—ADRA1A—central nervous system—epilepsy syndrome	0.000182	0.00434	CbGeAlD
Pseudoephedrine—MAOA—central nervous system—epilepsy syndrome	0.000181	0.0043	CbGeAlD
Pseudoephedrine—ADRA1A—cerebellum—epilepsy syndrome	0.000178	0.00424	CbGeAlD
Pseudoephedrine—SLC6A4—brain—epilepsy syndrome	0.000177	0.00421	CbGeAlD
Pseudoephedrine—MAOA—cerebellum—epilepsy syndrome	0.000177	0.0042	CbGeAlD
Pseudoephedrine—ADRA2A—midbrain—epilepsy syndrome	0.000175	0.00417	CbGeAlD
Pseudoephedrine—ADRA2A—spinal cord—epilepsy syndrome	0.000171	0.00407	CbGeAlD
Pseudoephedrine—SLC6A2—brain—epilepsy syndrome	0.000156	0.00371	CbGeAlD
Pseudoephedrine—ADRA2A—head—epilepsy syndrome	0.000152	0.00362	CbGeAlD
Pseudoephedrine—ADRA1A—brain—epilepsy syndrome	0.000145	0.00345	CbGeAlD
Pseudoephedrine—ADRA2A—nervous system—epilepsy syndrome	0.000144	0.00343	CbGeAlD
Pseudoephedrine—MAOA—brain—epilepsy syndrome	0.000143	0.00342	CbGeAlD
Pseudoephedrine—ADRA2A—central nervous system—epilepsy syndrome	0.000139	0.0033	CbGeAlD
Pseudoephedrine—ADRA2A—cerebellum—epilepsy syndrome	0.000136	0.00323	CbGeAlD
Pseudoephedrine—Ephedrine—BCHE—epilepsy syndrome	0.000129	0.0436	CrCbGaD
Pseudoephedrine—Phenylpropanolamine—ADRA2A—epilepsy syndrome	0.000119	0.04	CrCbGaD
Pseudoephedrine—CYP2D6—head—epilepsy syndrome	0.000118	0.0028	CbGeAlD
Pseudoephedrine—CYP2D6—nervous system—epilepsy syndrome	0.000112	0.00266	CbGeAlD
Pseudoephedrine—ADRA2A—brain—epilepsy syndrome	0.00011	0.00262	CbGeAlD
Pseudoephedrine—CYP2D6—central nervous system—epilepsy syndrome	0.000107	0.00256	CbGeAlD
Pseudoephedrine—CYP2D6—cerebellum—epilepsy syndrome	0.000105	0.0025	CbGeAlD
Pseudoephedrine—Dyspnoea—Phenytoin—epilepsy syndrome	0.000104	0.000821	CcSEcCtD
Pseudoephedrine—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000103	0.000817	CcSEcCtD
Pseudoephedrine—Dyspepsia—Clonazepam—epilepsy syndrome	0.000103	0.000816	CcSEcCtD
Pseudoephedrine—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000103	0.000815	CcSEcCtD
Pseudoephedrine—Nausea—Clobazam—epilepsy syndrome	0.000103	0.000814	CcSEcCtD
Pseudoephedrine—Asthenia—Propofol—epilepsy syndrome	0.000103	0.000814	CcSEcCtD
Pseudoephedrine—Tension—Valproic Acid—epilepsy syndrome	0.000103	0.000812	CcSEcCtD
Pseudoephedrine—Dyspepsia—Phenytoin—epilepsy syndrome	0.000103	0.000811	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Felbamate—epilepsy syndrome	0.000102	0.00081	CcSEcCtD
Pseudoephedrine—Anorexia—Lamotrigine—epilepsy syndrome	0.000102	0.00081	CcSEcCtD
Pseudoephedrine—Dizziness—Acetazolamide—epilepsy syndrome	0.000102	0.000808	CcSEcCtD
Pseudoephedrine—Angina pectoris—Topiramate—epilepsy syndrome	0.000102	0.000807	CcSEcCtD
Pseudoephedrine—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000102	0.000806	CcSEcCtD
Pseudoephedrine—Decreased appetite—Clonazepam—epilepsy syndrome	0.000102	0.000806	CcSEcCtD
Pseudoephedrine—Nervousness—Valproic Acid—epilepsy syndrome	0.000102	0.000803	CcSEcCtD
Pseudoephedrine—Bradycardia—Gabapentin—epilepsy syndrome	0.000101	0.000802	CcSEcCtD
Pseudoephedrine—Decreased appetite—Phenytoin—epilepsy syndrome	0.000101	0.000801	CcSEcCtD
Pseudoephedrine—Asthenia—Midazolam—epilepsy syndrome	0.000101	0.000797	CcSEcCtD
Pseudoephedrine—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000101	0.000796	CcSEcCtD
Pseudoephedrine—Muscle spasms—Valproic Acid—epilepsy syndrome	0.000101	0.000795	CcSEcCtD
Pseudoephedrine—Insomnia—Carbamazepine—epilepsy syndrome	0.000101	0.000795	CcSEcCtD
Pseudoephedrine—Pain—Clonazepam—epilepsy syndrome	0.0001	0.000793	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Zonisamide—epilepsy syndrome	0.0001	0.000793	CcSEcCtD
Pseudoephedrine—Asthenia—Levetiracetam—epilepsy syndrome	9.95e-05	0.000787	CcSEcCtD
Pseudoephedrine—Hallucination—Gabapentin—epilepsy syndrome	9.91e-05	0.000784	CcSEcCtD
Pseudoephedrine—Dyspnoea—Carbamazepine—epilepsy syndrome	9.91e-05	0.000784	CcSEcCtD
Pseudoephedrine—Pain—Oxcarbazepine—epilepsy syndrome	9.91e-05	0.000783	CcSEcCtD
Pseudoephedrine—Body temperature increased—Felbamate—epilepsy syndrome	9.83e-05	0.000777	CcSEcCtD
Pseudoephedrine—Vomiting—Acetazolamide—epilepsy syndrome	9.83e-05	0.000777	CcSEcCtD
Pseudoephedrine—Tremor—Valproic Acid—epilepsy syndrome	9.8e-05	0.000775	CcSEcCtD
Pseudoephedrine—Dysuria—Topiramate—epilepsy syndrome	9.79e-05	0.000774	CcSEcCtD
Pseudoephedrine—Dyspepsia—Carbamazepine—epilepsy syndrome	9.79e-05	0.000774	CcSEcCtD
Pseudoephedrine—Insomnia—Lamotrigine—epilepsy syndrome	9.72e-05	0.000768	CcSEcCtD
Pseudoephedrine—Arrhythmia—Pregabalin—epilepsy syndrome	9.71e-05	0.000767	CcSEcCtD
Pseudoephedrine—Headache—Acetazolamide—epilepsy syndrome	9.68e-05	0.000765	CcSEcCtD
Pseudoephedrine—Decreased appetite—Carbamazepine—epilepsy syndrome	9.67e-05	0.000764	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Clonazepam—epilepsy syndrome	9.66e-05	0.000764	CcSEcCtD
Pseudoephedrine—Body temperature increased—Zonisamide—epilepsy syndrome	9.62e-05	0.00076	CcSEcCtD
Pseudoephedrine—Agitation—Valproic Acid—epilepsy syndrome	9.62e-05	0.00076	CcSEcCtD
Pseudoephedrine—Asthenia—Fosphenytoin—epilepsy syndrome	9.6e-05	0.000759	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Phenytoin—epilepsy syndrome	9.6e-05	0.000759	CcSEcCtD
Pseudoephedrine—Dyspnoea—Lamotrigine—epilepsy syndrome	9.58e-05	0.000757	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	9.55e-05	0.000755	CcSEcCtD
Pseudoephedrine—Pain—Carbamazepine—epilepsy syndrome	9.51e-05	0.000752	CcSEcCtD
Pseudoephedrine—Dizziness—Propofol—epilepsy syndrome	9.49e-05	0.00075	CcSEcCtD
Pseudoephedrine—Dyspepsia—Lamotrigine—epilepsy syndrome	9.46e-05	0.000748	CcSEcCtD
Pseudoephedrine—Vertigo—Valproic Acid—epilepsy syndrome	9.4e-05	0.000743	CcSEcCtD
Pseudoephedrine—Asthenia—Vigabatrin—epilepsy syndrome	9.36e-05	0.00074	CcSEcCtD
Pseudoephedrine—Decreased appetite—Lamotrigine—epilepsy syndrome	9.34e-05	0.000738	CcSEcCtD
Pseudoephedrine—Dizziness—Midazolam—epilepsy syndrome	9.29e-05	0.000734	CcSEcCtD
Pseudoephedrine—Tension—Pregabalin—epilepsy syndrome	9.28e-05	0.000734	CcSEcCtD
Pseudoephedrine—Body temperature increased—Clonazepam—epilepsy syndrome	9.27e-05	0.000733	CcSEcCtD
Pseudoephedrine—Palpitations—Valproic Acid—epilepsy syndrome	9.25e-05	0.000731	CcSEcCtD
Pseudoephedrine—Asthenia—Diazepam—epilepsy syndrome	9.22e-05	0.000729	CcSEcCtD
Pseudoephedrine—Body temperature increased—Phenytoin—epilepsy syndrome	9.21e-05	0.000728	CcSEcCtD
Pseudoephedrine—Pain—Lamotrigine—epilepsy syndrome	9.19e-05	0.000726	CcSEcCtD
Pseudoephedrine—Nervousness—Pregabalin—epilepsy syndrome	9.19e-05	0.000726	CcSEcCtD
Pseudoephedrine—Nausea—Acetazolamide—epilepsy syndrome	9.18e-05	0.000726	CcSEcCtD
Pseudoephedrine—Dizziness—Levetiracetam—epilepsy syndrome	9.17e-05	0.000725	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Carbamazepine—epilepsy syndrome	9.16e-05	0.000724	CcSEcCtD
Pseudoephedrine—Body temperature increased—Oxcarbazepine—epilepsy syndrome	9.16e-05	0.000724	CcSEcCtD
Pseudoephedrine—Vomiting—Propofol—epilepsy syndrome	9.13e-05	0.000721	CcSEcCtD
Pseudoephedrine—Muscle spasms—Pregabalin—epilepsy syndrome	9.09e-05	0.000719	CcSEcCtD
Pseudoephedrine—Rash—Propofol—epilepsy syndrome	9.05e-05	0.000715	CcSEcCtD
Pseudoephedrine—Dermatitis—Propofol—epilepsy syndrome	9.04e-05	0.000715	CcSEcCtD
Pseudoephedrine—Hypertension—Valproic Acid—epilepsy syndrome	9.03e-05	0.000714	CcSEcCtD
Pseudoephedrine—Headache—Propofol—epilepsy syndrome	8.99e-05	0.000711	CcSEcCtD
Pseudoephedrine—Vomiting—Midazolam—epilepsy syndrome	8.93e-05	0.000706	CcSEcCtD
Pseudoephedrine—Asthenia—Felbamate—epilepsy syndrome	8.92e-05	0.000705	CcSEcCtD
Pseudoephedrine—Chest pain—Valproic Acid—epilepsy syndrome	8.91e-05	0.000704	CcSEcCtD
Pseudoephedrine—Anxiety—Valproic Acid—epilepsy syndrome	8.88e-05	0.000702	CcSEcCtD
Pseudoephedrine—Tremor—Pregabalin—epilepsy syndrome	8.86e-05	0.000701	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Lamotrigine—epilepsy syndrome	8.86e-05	0.0007	CcSEcCtD
Pseudoephedrine—Rash—Midazolam—epilepsy syndrome	8.85e-05	0.0007	CcSEcCtD
Pseudoephedrine—Dizziness—Fosphenytoin—epilepsy syndrome	8.85e-05	0.0007	CcSEcCtD
Pseudoephedrine—Dermatitis—Midazolam—epilepsy syndrome	8.85e-05	0.000699	CcSEcCtD
Pseudoephedrine—Vomiting—Levetiracetam—epilepsy syndrome	8.82e-05	0.000697	CcSEcCtD
Pseudoephedrine—Headache—Midazolam—epilepsy syndrome	8.8e-05	0.000695	CcSEcCtD
Pseudoephedrine—Body temperature increased—Carbamazepine—epilepsy syndrome	8.79e-05	0.000695	CcSEcCtD
Pseudoephedrine—Rash—Levetiracetam—epilepsy syndrome	8.74e-05	0.000691	CcSEcCtD
Pseudoephedrine—Dermatitis—Levetiracetam—epilepsy syndrome	8.74e-05	0.000691	CcSEcCtD
Pseudoephedrine—Asthenia—Zonisamide—epilepsy syndrome	8.73e-05	0.00069	CcSEcCtD
Pseudoephedrine—Agitation—Pregabalin—epilepsy syndrome	8.69e-05	0.000687	CcSEcCtD
Pseudoephedrine—Headache—Levetiracetam—epilepsy syndrome	8.69e-05	0.000687	CcSEcCtD
Pseudoephedrine—Dizziness—Vigabatrin—epilepsy syndrome	8.63e-05	0.000682	CcSEcCtD
Pseudoephedrine—Confusional state—Valproic Acid—epilepsy syndrome	8.61e-05	0.000681	CcSEcCtD
Pseudoephedrine—Bradycardia—Topiramate—epilepsy syndrome	8.53e-05	0.000675	CcSEcCtD
Pseudoephedrine—Nausea—Propofol—epilepsy syndrome	8.53e-05	0.000674	CcSEcCtD
Pseudoephedrine—CYP2D6—brain—epilepsy syndrome	8.53e-05	0.00203	CbGeAlD
Pseudoephedrine—Tension—Gabapentin—epilepsy syndrome	8.51e-05	0.000673	CcSEcCtD
Pseudoephedrine—Vomiting—Fosphenytoin—epilepsy syndrome	8.51e-05	0.000673	CcSEcCtD
Pseudoephedrine—Vertigo—Pregabalin—epilepsy syndrome	8.5e-05	0.000672	CcSEcCtD
Pseudoephedrine—Body temperature increased—Lamotrigine—epilepsy syndrome	8.5e-05	0.000672	CcSEcCtD
Pseudoephedrine—Dizziness—Diazepam—epilepsy syndrome	8.49e-05	0.000671	CcSEcCtD
Pseudoephedrine—Rash—Fosphenytoin—epilepsy syndrome	8.44e-05	0.000667	CcSEcCtD
Pseudoephedrine—Dermatitis—Fosphenytoin—epilepsy syndrome	8.43e-05	0.000667	CcSEcCtD
Pseudoephedrine—Nervousness—Gabapentin—epilepsy syndrome	8.42e-05	0.000666	CcSEcCtD
Pseudoephedrine—Asthenia—Clonazepam—epilepsy syndrome	8.41e-05	0.000665	CcSEcCtD
Pseudoephedrine—Headache—Fosphenytoin—epilepsy syndrome	8.38e-05	0.000663	CcSEcCtD
Pseudoephedrine—Palpitations—Pregabalin—epilepsy syndrome	8.36e-05	0.000661	CcSEcCtD
Pseudoephedrine—Asthenia—Phenytoin—epilepsy syndrome	8.36e-05	0.000661	CcSEcCtD
Pseudoephedrine—Nausea—Midazolam—epilepsy syndrome	8.34e-05	0.000659	CcSEcCtD
Pseudoephedrine—Hallucination—Topiramate—epilepsy syndrome	8.34e-05	0.000659	CcSEcCtD
Pseudoephedrine—Muscle spasms—Gabapentin—epilepsy syndrome	8.34e-05	0.000659	CcSEcCtD
Pseudoephedrine—Tachycardia—Valproic Acid—epilepsy syndrome	8.33e-05	0.000659	CcSEcCtD
Pseudoephedrine—Asthenia—Oxcarbazepine—epilepsy syndrome	8.31e-05	0.000657	CcSEcCtD
Pseudoephedrine—Vomiting—Vigabatrin—epilepsy syndrome	8.3e-05	0.000656	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	8.26e-05	0.000653	CcSEcCtD
Pseudoephedrine—Nausea—Levetiracetam—epilepsy syndrome	8.24e-05	0.000651	CcSEcCtD
Pseudoephedrine—Rash—Vigabatrin—epilepsy syndrome	8.23e-05	0.00065	CcSEcCtD
Pseudoephedrine—Dizziness—Felbamate—epilepsy syndrome	8.22e-05	0.00065	CcSEcCtD
Pseudoephedrine—Dermatitis—Vigabatrin—epilepsy syndrome	8.22e-05	0.00065	CcSEcCtD
Pseudoephedrine—Headache—Vigabatrin—epilepsy syndrome	8.17e-05	0.000646	CcSEcCtD
Pseudoephedrine—Hypertension—Pregabalin—epilepsy syndrome	8.17e-05	0.000646	CcSEcCtD
Pseudoephedrine—Vomiting—Diazepam—epilepsy syndrome	8.17e-05	0.000646	CcSEcCtD
Pseudoephedrine—Anorexia—Valproic Acid—epilepsy syndrome	8.14e-05	0.000643	CcSEcCtD
Pseudoephedrine—Tremor—Gabapentin—epilepsy syndrome	8.13e-05	0.000642	CcSEcCtD
Pseudoephedrine—Rash—Diazepam—epilepsy syndrome	8.1e-05	0.00064	CcSEcCtD
Pseudoephedrine—Dermatitis—Diazepam—epilepsy syndrome	8.09e-05	0.00064	CcSEcCtD
Pseudoephedrine—Phentermine—SLC6A4—epilepsy syndrome	8.07e-05	0.0272	CrCbGaD
Pseudoephedrine—Chest pain—Pregabalin—epilepsy syndrome	8.05e-05	0.000637	CcSEcCtD
Pseudoephedrine—Dizziness—Zonisamide—epilepsy syndrome	8.05e-05	0.000636	CcSEcCtD
Pseudoephedrine—Headache—Diazepam—epilepsy syndrome	8.05e-05	0.000636	CcSEcCtD
Pseudoephedrine—Anxiety—Pregabalin—epilepsy syndrome	8.03e-05	0.000634	CcSEcCtD
Pseudoephedrine—Asthenia—Carbamazepine—epilepsy syndrome	7.98e-05	0.000631	CcSEcCtD
Pseudoephedrine—Agitation—Gabapentin—epilepsy syndrome	7.97e-05	0.00063	CcSEcCtD
Pseudoephedrine—Nausea—Fosphenytoin—epilepsy syndrome	7.95e-05	0.000628	CcSEcCtD
Pseudoephedrine—Vomiting—Felbamate—epilepsy syndrome	7.9e-05	0.000625	CcSEcCtD
Pseudoephedrine—Rash—Felbamate—epilepsy syndrome	7.84e-05	0.00062	CcSEcCtD
Pseudoephedrine—Dermatitis—Felbamate—epilepsy syndrome	7.83e-05	0.000619	CcSEcCtD
Pseudoephedrine—Vertigo—Gabapentin—epilepsy syndrome	7.79e-05	0.000616	CcSEcCtD
Pseudoephedrine—Headache—Felbamate—epilepsy syndrome	7.79e-05	0.000616	CcSEcCtD
Pseudoephedrine—Confusional state—Pregabalin—epilepsy syndrome	7.78e-05	0.000615	CcSEcCtD
Pseudoephedrine—Dizziness—Clonazepam—epilepsy syndrome	7.76e-05	0.000613	CcSEcCtD
Pseudoephedrine—Nausea—Vigabatrin—epilepsy syndrome	7.75e-05	0.000613	CcSEcCtD
Pseudoephedrine—Vomiting—Zonisamide—epilepsy syndrome	7.74e-05	0.000612	CcSEcCtD
Pseudoephedrine—Insomnia—Valproic Acid—epilepsy syndrome	7.72e-05	0.000611	CcSEcCtD
Pseudoephedrine—Asthenia—Lamotrigine—epilepsy syndrome	7.71e-05	0.00061	CcSEcCtD
Pseudoephedrine—Dizziness—Phenytoin—epilepsy syndrome	7.7e-05	0.000609	CcSEcCtD
Pseudoephedrine—Rash—Zonisamide—epilepsy syndrome	7.67e-05	0.000607	CcSEcCtD
Pseudoephedrine—Palpitations—Gabapentin—epilepsy syndrome	7.67e-05	0.000606	CcSEcCtD
Pseudoephedrine—Dermatitis—Zonisamide—epilepsy syndrome	7.67e-05	0.000606	CcSEcCtD
Pseudoephedrine—Dizziness—Oxcarbazepine—epilepsy syndrome	7.66e-05	0.000606	CcSEcCtD
Pseudoephedrine—Nausea—Diazepam—epilepsy syndrome	7.63e-05	0.000603	CcSEcCtD
Pseudoephedrine—Headache—Zonisamide—epilepsy syndrome	7.62e-05	0.000603	CcSEcCtD
Pseudoephedrine—Dyspnoea—Valproic Acid—epilepsy syndrome	7.61e-05	0.000602	CcSEcCtD
Pseudoephedrine—Methamphetamine—ADRA2A—epilepsy syndrome	7.54e-05	0.0254	CrCbGaD
Pseudoephedrine—Tachycardia—Pregabalin—epilepsy syndrome	7.53e-05	0.000596	CcSEcCtD
Pseudoephedrine—Dyspepsia—Valproic Acid—epilepsy syndrome	7.52e-05	0.000594	CcSEcCtD
Pseudoephedrine—Hypertension—Gabapentin—epilepsy syndrome	7.49e-05	0.000592	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Pregabalin—epilepsy syndrome	7.46e-05	0.00059	CcSEcCtD
Pseudoephedrine—Vomiting—Clonazepam—epilepsy syndrome	7.46e-05	0.000589	CcSEcCtD
Pseudoephedrine—Decreased appetite—Valproic Acid—epilepsy syndrome	7.42e-05	0.000587	CcSEcCtD
Pseudoephedrine—Vomiting—Phenytoin—epilepsy syndrome	7.41e-05	0.000586	CcSEcCtD
Pseudoephedrine—Rash—Clonazepam—epilepsy syndrome	7.39e-05	0.000585	CcSEcCtD
Pseudoephedrine—Dermatitis—Clonazepam—epilepsy syndrome	7.39e-05	0.000584	CcSEcCtD
Pseudoephedrine—Chest pain—Gabapentin—epilepsy syndrome	7.38e-05	0.000584	CcSEcCtD
Pseudoephedrine—Nausea—Felbamate—epilepsy syndrome	7.38e-05	0.000584	CcSEcCtD
Pseudoephedrine—Vomiting—Oxcarbazepine—epilepsy syndrome	7.37e-05	0.000582	CcSEcCtD
Pseudoephedrine—Anxiety—Gabapentin—epilepsy syndrome	7.36e-05	0.000582	CcSEcCtD
Pseudoephedrine—Anorexia—Pregabalin—epilepsy syndrome	7.36e-05	0.000582	CcSEcCtD
Pseudoephedrine—Dizziness—Carbamazepine—epilepsy syndrome	7.35e-05	0.000581	CcSEcCtD
Pseudoephedrine—Headache—Clonazepam—epilepsy syndrome	7.35e-05	0.000581	CcSEcCtD
Pseudoephedrine—Rash—Phenytoin—epilepsy syndrome	7.34e-05	0.000581	CcSEcCtD
Pseudoephedrine—Dermatitis—Phenytoin—epilepsy syndrome	7.34e-05	0.00058	CcSEcCtD
Pseudoephedrine—Rash—Oxcarbazepine—epilepsy syndrome	7.31e-05	0.000578	CcSEcCtD
Pseudoephedrine—Pain—Valproic Acid—epilepsy syndrome	7.3e-05	0.000577	CcSEcCtD
Pseudoephedrine—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.3e-05	0.000577	CcSEcCtD
Pseudoephedrine—Headache—Phenytoin—epilepsy syndrome	7.3e-05	0.000577	CcSEcCtD
Pseudoephedrine—Headache—Oxcarbazepine—epilepsy syndrome	7.26e-05	0.000574	CcSEcCtD
Pseudoephedrine—Nausea—Zonisamide—epilepsy syndrome	7.23e-05	0.000571	CcSEcCtD
Pseudoephedrine—Tension—Topiramate—epilepsy syndrome	7.16e-05	0.000566	CcSEcCtD
Pseudoephedrine—Confusional state—Gabapentin—epilepsy syndrome	7.14e-05	0.000564	CcSEcCtD
Pseudoephedrine—Dizziness—Lamotrigine—epilepsy syndrome	7.11e-05	0.000562	CcSEcCtD
Pseudoephedrine—Nervousness—Topiramate—epilepsy syndrome	7.09e-05	0.00056	CcSEcCtD
Pseudoephedrine—Selegiline—CYP2C19—epilepsy syndrome	7.08e-05	0.0238	CrCbGaD
Pseudoephedrine—Vomiting—Carbamazepine—epilepsy syndrome	7.07e-05	0.000559	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Valproic Acid—epilepsy syndrome	7.04e-05	0.000556	CcSEcCtD
Pseudoephedrine—Muscle spasms—Topiramate—epilepsy syndrome	7.02e-05	0.000555	CcSEcCtD
Pseudoephedrine—Rash—Carbamazepine—epilepsy syndrome	7.01e-05	0.000554	CcSEcCtD
Pseudoephedrine—Dermatitis—Carbamazepine—epilepsy syndrome	7e-05	0.000554	CcSEcCtD
Pseudoephedrine—Insomnia—Pregabalin—epilepsy syndrome	6.98e-05	0.000552	CcSEcCtD
Pseudoephedrine—Nausea—Clonazepam—epilepsy syndrome	6.97e-05	0.000551	CcSEcCtD
Pseudoephedrine—Headache—Carbamazepine—epilepsy syndrome	6.97e-05	0.000551	CcSEcCtD
Pseudoephedrine—Nausea—Phenytoin—epilepsy syndrome	6.92e-05	0.000547	CcSEcCtD
Pseudoephedrine—Tachycardia—Gabapentin—epilepsy syndrome	6.91e-05	0.000546	CcSEcCtD
Pseudoephedrine—Dyspnoea—Pregabalin—epilepsy syndrome	6.88e-05	0.000544	CcSEcCtD
Pseudoephedrine—Nausea—Oxcarbazepine—epilepsy syndrome	6.88e-05	0.000544	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Gabapentin—epilepsy syndrome	6.84e-05	0.000541	CcSEcCtD
Pseudoephedrine—Tremor—Topiramate—epilepsy syndrome	6.84e-05	0.00054	CcSEcCtD
Pseudoephedrine—Vomiting—Lamotrigine—epilepsy syndrome	6.83e-05	0.00054	CcSEcCtD
Pseudoephedrine—Rash—Lamotrigine—epilepsy syndrome	6.78e-05	0.000536	CcSEcCtD
Pseudoephedrine—Dermatitis—Lamotrigine—epilepsy syndrome	6.77e-05	0.000535	CcSEcCtD
Pseudoephedrine—Body temperature increased—Valproic Acid—epilepsy syndrome	6.75e-05	0.000534	CcSEcCtD
Pseudoephedrine—Anorexia—Gabapentin—epilepsy syndrome	6.75e-05	0.000533	CcSEcCtD
Pseudoephedrine—Headache—Lamotrigine—epilepsy syndrome	6.73e-05	0.000532	CcSEcCtD
Pseudoephedrine—Decreased appetite—Pregabalin—epilepsy syndrome	6.71e-05	0.000531	CcSEcCtD
Pseudoephedrine—Agitation—Topiramate—epilepsy syndrome	6.71e-05	0.00053	CcSEcCtD
Pseudoephedrine—Nausea—Carbamazepine—epilepsy syndrome	6.6e-05	0.000522	CcSEcCtD
Pseudoephedrine—Pain—Pregabalin—epilepsy syndrome	6.6e-05	0.000522	CcSEcCtD
Pseudoephedrine—Vertigo—Topiramate—epilepsy syndrome	6.56e-05	0.000518	CcSEcCtD
Pseudoephedrine—Palpitations—Topiramate—epilepsy syndrome	6.45e-05	0.00051	CcSEcCtD
Pseudoephedrine—Insomnia—Gabapentin—epilepsy syndrome	6.4e-05	0.000506	CcSEcCtD
Pseudoephedrine—Nausea—Lamotrigine—epilepsy syndrome	6.38e-05	0.000505	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Pregabalin—epilepsy syndrome	6.36e-05	0.000503	CcSEcCtD
Pseudoephedrine—Dyspnoea—Gabapentin—epilepsy syndrome	6.31e-05	0.000499	CcSEcCtD
Pseudoephedrine—Hypertension—Topiramate—epilepsy syndrome	6.3e-05	0.000498	CcSEcCtD
Pseudoephedrine—Dyspepsia—Gabapentin—epilepsy syndrome	6.23e-05	0.000493	CcSEcCtD
Pseudoephedrine—Chest pain—Topiramate—epilepsy syndrome	6.21e-05	0.000491	CcSEcCtD
Pseudoephedrine—Amphetamine—SLC6A4—epilepsy syndrome	6.21e-05	0.0209	CrCbGaD
Pseudoephedrine—Anxiety—Topiramate—epilepsy syndrome	6.19e-05	0.000489	CcSEcCtD
Pseudoephedrine—Decreased appetite—Gabapentin—epilepsy syndrome	6.15e-05	0.000486	CcSEcCtD
Pseudoephedrine—Asthenia—Valproic Acid—epilepsy syndrome	6.13e-05	0.000484	CcSEcCtD
Pseudoephedrine—Body temperature increased—Pregabalin—epilepsy syndrome	6.1e-05	0.000482	CcSEcCtD
Pseudoephedrine—Pain—Gabapentin—epilepsy syndrome	6.05e-05	0.000479	CcSEcCtD
Pseudoephedrine—Confusional state—Topiramate—epilepsy syndrome	6.01e-05	0.000475	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Gabapentin—epilepsy syndrome	5.83e-05	0.000461	CcSEcCtD
Pseudoephedrine—Tachycardia—Topiramate—epilepsy syndrome	5.81e-05	0.00046	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Topiramate—epilepsy syndrome	5.76e-05	0.000455	CcSEcCtD
Pseudoephedrine—Methamphetamine—SLC6A4—epilepsy syndrome	5.75e-05	0.0194	CrCbGaD
Pseudoephedrine—Anorexia—Topiramate—epilepsy syndrome	5.68e-05	0.000449	CcSEcCtD
Pseudoephedrine—Phentermine—CYP2D6—epilepsy syndrome	5.67e-05	0.0191	CrCbGaD
Pseudoephedrine—Atomoxetine—SLC6A4—epilepsy syndrome	5.66e-05	0.0191	CrCbGaD
Pseudoephedrine—Dizziness—Valproic Acid—epilepsy syndrome	5.65e-05	0.000446	CcSEcCtD
Pseudoephedrine—Body temperature increased—Gabapentin—epilepsy syndrome	5.6e-05	0.000442	CcSEcCtD
Pseudoephedrine—Asthenia—Pregabalin—epilepsy syndrome	5.54e-05	0.000438	CcSEcCtD
Pseudoephedrine—Benzyl alcohol—CYP2D6—epilepsy syndrome	5.47e-05	0.0184	CrCbGaD
Pseudoephedrine—Vomiting—Valproic Acid—epilepsy syndrome	5.43e-05	0.000429	CcSEcCtD
Pseudoephedrine—Dextroamphetamine—CYP2D6—epilepsy syndrome	5.41e-05	0.0182	CrCbGaD
Pseudoephedrine—Insomnia—Topiramate—epilepsy syndrome	5.39e-05	0.000426	CcSEcCtD
Pseudoephedrine—Rash—Valproic Acid—epilepsy syndrome	5.38e-05	0.000426	CcSEcCtD
Pseudoephedrine—Dermatitis—Valproic Acid—epilepsy syndrome	5.38e-05	0.000425	CcSEcCtD
Pseudoephedrine—Atomoxetine—CYP2C19—epilepsy syndrome	5.36e-05	0.0181	CrCbGaD
Pseudoephedrine—Headache—Valproic Acid—epilepsy syndrome	5.35e-05	0.000423	CcSEcCtD
Pseudoephedrine—Dyspnoea—Topiramate—epilepsy syndrome	5.31e-05	0.00042	CcSEcCtD
Pseudoephedrine—Selegiline—CYP2D6—epilepsy syndrome	5.25e-05	0.0177	CrCbGaD
Pseudoephedrine—Dyspepsia—Topiramate—epilepsy syndrome	5.24e-05	0.000414	CcSEcCtD
Pseudoephedrine—Decreased appetite—Topiramate—epilepsy syndrome	5.18e-05	0.000409	CcSEcCtD
Pseudoephedrine—Dizziness—Pregabalin—epilepsy syndrome	5.11e-05	0.000404	CcSEcCtD
Pseudoephedrine—Pain—Topiramate—epilepsy syndrome	5.09e-05	0.000403	CcSEcCtD
Pseudoephedrine—Asthenia—Gabapentin—epilepsy syndrome	5.08e-05	0.000402	CcSEcCtD
Pseudoephedrine—Nausea—Valproic Acid—epilepsy syndrome	5.07e-05	0.000401	CcSEcCtD
Pseudoephedrine—Vomiting—Pregabalin—epilepsy syndrome	4.91e-05	0.000388	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Topiramate—epilepsy syndrome	4.91e-05	0.000388	CcSEcCtD
Pseudoephedrine—Rash—Pregabalin—epilepsy syndrome	4.87e-05	0.000385	CcSEcCtD
Pseudoephedrine—Dermatitis—Pregabalin—epilepsy syndrome	4.86e-05	0.000384	CcSEcCtD
Pseudoephedrine—Headache—Pregabalin—epilepsy syndrome	4.84e-05	0.000382	CcSEcCtD
Pseudoephedrine—Body temperature increased—Topiramate—epilepsy syndrome	4.71e-05	0.000372	CcSEcCtD
Pseudoephedrine—Dizziness—Gabapentin—epilepsy syndrome	4.68e-05	0.00037	CcSEcCtD
Pseudoephedrine—Nausea—Pregabalin—epilepsy syndrome	4.59e-05	0.000363	CcSEcCtD
Pseudoephedrine—Vomiting—Gabapentin—epilepsy syndrome	4.5e-05	0.000356	CcSEcCtD
Pseudoephedrine—Rash—Gabapentin—epilepsy syndrome	4.46e-05	0.000353	CcSEcCtD
Pseudoephedrine—Dermatitis—Gabapentin—epilepsy syndrome	4.46e-05	0.000353	CcSEcCtD
Pseudoephedrine—Headache—Gabapentin—epilepsy syndrome	4.43e-05	0.000351	CcSEcCtD
Pseudoephedrine—Amphetamine—CYP2D6—epilepsy syndrome	4.36e-05	0.0147	CrCbGaD
Pseudoephedrine—Atomoxetine—HTR2A—epilepsy syndrome	4.35e-05	0.0147	CrCbGaD
Pseudoephedrine—Asthenia—Topiramate—epilepsy syndrome	4.27e-05	0.000338	CcSEcCtD
Pseudoephedrine—Nausea—Gabapentin—epilepsy syndrome	4.21e-05	0.000332	CcSEcCtD
Pseudoephedrine—Methamphetamine—CYP2D6—epilepsy syndrome	4.04e-05	0.0136	CrCbGaD
Pseudoephedrine—Atomoxetine—CYP2D6—epilepsy syndrome	3.98e-05	0.0134	CrCbGaD
Pseudoephedrine—Dizziness—Topiramate—epilepsy syndrome	3.94e-05	0.000311	CcSEcCtD
Pseudoephedrine—Vomiting—Topiramate—epilepsy syndrome	3.79e-05	0.000299	CcSEcCtD
Pseudoephedrine—Rash—Topiramate—epilepsy syndrome	3.76e-05	0.000297	CcSEcCtD
Pseudoephedrine—Dermatitis—Topiramate—epilepsy syndrome	3.75e-05	0.000297	CcSEcCtD
Pseudoephedrine—Selegiline—ABCB1—epilepsy syndrome	3.75e-05	0.0126	CrCbGaD
Pseudoephedrine—Headache—Topiramate—epilepsy syndrome	3.73e-05	0.000295	CcSEcCtD
Pseudoephedrine—Nausea—Topiramate—epilepsy syndrome	3.54e-05	0.00028	CcSEcCtD
Pseudoephedrine—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	2.72e-06	2.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	2.72e-06	2.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL2—epilepsy syndrome	2.7e-06	2.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—OXT—epilepsy syndrome	2.7e-06	2.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CRH—epilepsy syndrome	2.7e-06	2.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL3—epilepsy syndrome	2.7e-06	2.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HSPB1—epilepsy syndrome	2.7e-06	2.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCR3—epilepsy syndrome	2.67e-06	2.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.67e-06	2.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCR5—epilepsy syndrome	2.67e-06	2.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	2.66e-06	2.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—BCHE—epilepsy syndrome	2.65e-06	2.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	2.64e-06	2.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	2.62e-06	2.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HTR2A—epilepsy syndrome	2.61e-06	2.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NPY—epilepsy syndrome	2.6e-06	2.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ATP2A2—epilepsy syndrome	2.6e-06	2.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	2.59e-06	2.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	2.58e-06	2.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	2.58e-06	2.36e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	2.55e-06	2.34e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	2.55e-06	2.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	2.54e-06	2.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AGT—epilepsy syndrome	2.53e-06	2.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	2.53e-06	2.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SLC2A1—epilepsy syndrome	2.52e-06	2.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	2.52e-06	2.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	2.52e-06	2.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.52e-06	2.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TSC1—epilepsy syndrome	2.51e-06	2.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTK2B—epilepsy syndrome	2.51e-06	2.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HSPB1—epilepsy syndrome	2.51e-06	2.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CRH—epilepsy syndrome	2.51e-06	2.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL3—epilepsy syndrome	2.51e-06	2.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—OXT—epilepsy syndrome	2.51e-06	2.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL2—epilepsy syndrome	2.51e-06	2.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PLCB1—epilepsy syndrome	2.5e-06	2.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TH—epilepsy syndrome	2.49e-06	2.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCR5—epilepsy syndrome	2.48e-06	2.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	2.48e-06	2.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AGT—epilepsy syndrome	2.48e-06	2.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	2.46e-06	2.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCR2—epilepsy syndrome	2.44e-06	2.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SST—epilepsy syndrome	2.44e-06	2.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NTRK2—epilepsy syndrome	2.44e-06	2.24e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AGT—epilepsy syndrome	2.43e-06	2.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HTR2A—epilepsy syndrome	2.42e-06	2.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DUSP6—epilepsy syndrome	2.42e-06	2.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	2.39e-06	2.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ADRA2A—epilepsy syndrome	2.39e-06	2.2e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—APOE—epilepsy syndrome	2.38e-06	2.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PLAT—epilepsy syndrome	2.38e-06	2.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	2.37e-06	2.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	2.36e-06	2.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	2.34e-06	2.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.34e-06	2.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTK2B—epilepsy syndrome	2.33e-06	2.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TSC1—epilepsy syndrome	2.33e-06	2.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	2.32e-06	2.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	2.31e-06	2.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AGT—epilepsy syndrome	2.3e-06	2.11e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—AKT1—epilepsy syndrome	2.3e-06	2.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—BDKRB2—epilepsy syndrome	2.3e-06	2.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL12—epilepsy syndrome	2.3e-06	2.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—POMC—epilepsy syndrome	2.29e-06	2.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	2.29e-06	2.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PRKCB—epilepsy syndrome	2.29e-06	2.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6ST—epilepsy syndrome	2.28e-06	2.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCR2—epilepsy syndrome	2.27e-06	2.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SST—epilepsy syndrome	2.27e-06	2.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NTRK2—epilepsy syndrome	2.27e-06	2.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—JUNB—epilepsy syndrome	2.26e-06	2.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CNR1—epilepsy syndrome	2.26e-06	2.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DUSP6—epilepsy syndrome	2.25e-06	2.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PLCB1—epilepsy syndrome	2.25e-06	2.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	2.24e-06	2.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PLAT—epilepsy syndrome	2.21e-06	2.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR7—epilepsy syndrome	2.2e-06	2.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—SRC—epilepsy syndrome	2.18e-06	2e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—AKT1—epilepsy syndrome	2.17e-06	2e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	2.16e-06	1.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HBEGF—epilepsy syndrome	2.14e-06	1.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL12—epilepsy syndrome	2.14e-06	1.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—BDKRB2—epilepsy syndrome	2.14e-06	1.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—POMC—epilepsy syndrome	2.13e-06	1.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PRKCB—epilepsy syndrome	2.13e-06	1.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—VEGFA—epilepsy syndrome	2.12e-06	1.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	2.12e-06	1.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	2.12e-06	1.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	2.11e-06	1.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	2.1e-06	1.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT3—epilepsy syndrome	2.1e-06	1.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—JUNB—epilepsy syndrome	2.1e-06	1.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CNR1—epilepsy syndrome	2.1e-06	1.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	2.09e-06	1.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PLCB1—epilepsy syndrome	2.09e-06	1.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—POMC—epilepsy syndrome	2.08e-06	1.91e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.08e-06	1.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—HMOX1—epilepsy syndrome	2.08e-06	1.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	2.06e-06	1.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	2.05e-06	1.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CAT—epilepsy syndrome	2.05e-06	1.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	2.05e-06	1.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ADAM10—epilepsy syndrome	2.05e-06	1.88e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—POMC—epilepsy syndrome	2.05e-06	1.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR7—epilepsy syndrome	2.04e-06	1.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCL2—epilepsy syndrome	2.04e-06	1.87e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.03e-06	1.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.02e-06	1.86e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.02e-06	1.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	2e-06	1.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	1.99e-06	1.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	1.98e-06	1.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.98e-06	1.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	1.96e-06	1.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	1.95e-06	1.79e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	1.95e-06	1.79e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—AKT1—epilepsy syndrome	1.94e-06	1.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	1.94e-06	1.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	1.94e-06	1.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	1.92e-06	1.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	1.91e-06	1.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	1.9e-06	1.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	1.9e-06	1.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	1.9e-06	1.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	1.89e-06	1.74e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ALB—epilepsy syndrome	1.87e-06	1.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	1.86e-06	1.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GPX1—epilepsy syndrome	1.85e-06	1.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	1.85e-06	1.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	1.81e-06	1.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	1.81e-06	1.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	1.8e-06	1.65e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	1.78e-06	1.64e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	1.78e-06	1.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	1.77e-06	1.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	1.77e-06	1.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	1.77e-06	1.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	1.75e-06	1.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	1.73e-06	1.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	1.73e-06	1.59e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.73e-06	1.59e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.72e-06	1.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	1.72e-06	1.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	1.7e-06	1.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	1.7e-06	1.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	1.7e-06	1.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	1.69e-06	1.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	1.67e-06	1.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	1.66e-06	1.53e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.65e-06	1.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.64e-06	1.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	1.63e-06	1.5e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGS2—epilepsy syndrome	1.63e-06	1.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	1.63e-06	1.49e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.63e-06	1.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	1.63e-06	1.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AGT—epilepsy syndrome	1.63e-06	1.49e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TH—epilepsy syndrome	1.62e-06	1.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	1.62e-06	1.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOE—epilepsy syndrome	1.59e-06	1.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	1.58e-06	1.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	1.58e-06	1.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	1.58e-06	1.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	1.57e-06	1.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.54e-06	1.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.52e-06	1.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	1.52e-06	1.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	1.5e-06	1.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	1.49e-06	1.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	1.49e-06	1.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	1.46e-06	1.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	1.46e-06	1.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	1.46e-06	1.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	1.46e-06	1.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	1.43e-06	1.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	1.43e-06	1.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	1.4e-06	1.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—POMC—epilepsy syndrome	1.37e-06	1.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	1.36e-06	1.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	1.36e-06	1.25e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.35e-06	1.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	1.35e-06	1.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.35e-06	1.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.35e-06	1.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	1.35e-06	1.23e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.34e-06	1.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	1.33e-06	1.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	1.32e-06	1.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	1.3e-06	1.2e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.3e-06	1.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.26e-06	1.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.25e-06	1.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	1.25e-06	1.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ALB—epilepsy syndrome	1.25e-06	1.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	1.23e-06	1.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	1.22e-06	1.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	1.22e-06	1.12e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.21e-06	1.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	1.2e-06	1.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	1.2e-06	1.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	1.14e-06	1.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.14e-06	1.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	1.13e-06	1.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	1.12e-06	1.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.11e-06	1.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	1.1e-06	1.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	1.09e-06	1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	1.09e-06	1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	1.09e-06	9.99e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	1.07e-06	9.82e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	1.06e-06	9.77e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.06e-06	9.72e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	1.04e-06	9.56e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.04e-06	9.52e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	1.03e-06	9.48e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	1.01e-06	9.28e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	1.01e-06	9.28e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	1.01e-06	9.27e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	9.91e-07	9.1e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	9.81e-07	9.01e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	9.6e-07	8.81e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	9.56e-07	8.77e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	9.39e-07	8.62e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	9.35e-07	8.58e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	9.21e-07	8.45e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	9.2e-07	8.44e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	9.11e-07	8.37e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—POMC—epilepsy syndrome	8.91e-07	8.18e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	8.85e-07	8.13e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	8.61e-07	7.91e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	8.55e-07	7.85e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	8.47e-07	7.77e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	8.35e-07	7.67e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	8.23e-07	7.55e-06	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AKT1—epilepsy syndrome	8.21e-07	7.53e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ALB—epilepsy syndrome	8.13e-07	7.46e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	8e-07	7.35e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	7.94e-07	7.29e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	7.76e-07	7.12e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	7.73e-07	7.1e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	7.38e-07	6.77e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	7.19e-07	6.6e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	7.11e-07	6.53e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	6.1e-07	5.6e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	5.97e-07	5.48e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	5.48e-07	5.03e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	4.93e-07	4.53e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	4.58e-07	4.21e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	3.57e-07	3.28e-06	CbGpPWpGaD
